Can steroids enhance or reduce ruxolitinib's effectiveness?

Can steroids reduce ruxolitinib's effectiveness?

Steroids like prednisone and dexamethasone are often combined with ruxolitinib in clinical practice, especially for patients who need immediate symptom control or who have acute graft-versus-host disease. The two classes of drugs work through different pathways, so they generally do not interfere with each other. Clinical trials and real-world data show that the combination remains effective for treating myelofibrosis and graft-versus-host disease.

What happens if steroids are tapered while on ruxolitinib?

When steroids are tapered in the presence of ruxoliticib, many patients continue to show ruxolitinib-dependent improvements in symptoms and spleen size. Data from the COMFORT trials showed that ruxolitinib remains active even after steroid use is reduced or discontinued. Patients who are able to taper steroids successfully usually maintain their response without loss of efficacy.

Can steroids enhance ruxolitinib's effectiveness?

Steroids themselves do not amplify the JAK2 pathway inhibition produced by ruxolitinib. They provide additional anti-inflammatory and immunosuppressive effects that can complement ruxolitinib, especially when patients have severe itching or constitutional symptoms that ruxolitinib alone may not fully address. The combination appears to can improve overall symptom scores in man